PRL and breast cancer: Indeed, prolactin signaling has been implicated in promoting ER+ tumorigenesis in mice [78] and transgenic overexpression of rat prolactin ligand rPrl in the mouse mammary gland induced the formation of ER+ mammary tumors [57].